Tissue engineering of blood vessel

Area of Science:

• Biomaterials Science
• Regenerative Medicine
• Vascular Surgery

Background:

• Synthetic vascular grafts frequently fail in small-diameter bypass surgeries due to thrombosis and material degradation.
• Current synthetic grafts lack growth potential, leading to long-term complications like stenosis and infection.
• Tissue engineering presents a viable alternative for developing functional, biocompatible blood vessels.

Purpose of the Study:

• To review the significant advancements in tissue-engineered blood vessel (TEBV) development.
• To discuss key components and technologies involved in TEBV construction.
• To highlight clinical applications and remaining challenges in the field.

Main Methods:

• Review of literature on cell sources for TEBVs, including vascular cells.
• Analysis of biodegradable scaffolds used in TEBV fabrication.
• Examination of construction technologies and in vitro/in vivo studies of TEBVs.

Main Results:

• Successful in vitro construction of tissue-engineered blood vessels (TEBVs).
• Demonstrated efficacy of TEBVs in repairing vascular defects in animal models.
• Progress in cell sourcing, scaffold design, and construction techniques.

Conclusions:

• Tissue-engineered blood vessels (TEBVs) represent a promising alternative to synthetic grafts for bypass surgery.
• Continued research in cell sources, scaffolds, and construction is crucial for clinical translation.
• Addressing challenges will enable wider application of TEBVs in treating vascular diseases.